bta undervalued and manipulated, page-3

funny thing is a year ago (or thereabouts) stock pickers such as fat prophets had a "buy" on BTA at around $1.80. Now, with the efficacy of Relenza unquestioned, LANI proceeding through trials as anticipated, HRV posting good results from phase 2a studies, rapidly growing revenue stream from Relenza etc and these stockpickers (so far as i can tell) strangely (sullenly?) silent. This can't be good for the sp.

topped uday at $1.21